Dr. Ugai is a junior faculty member at Brigham and Women's Hospital/Harvard Medical School and an MD/PhD physician scientist with expertise in pathology, clinical oncology, cancer epidemiology, and molecular epidemiology. His current research focuses on early-onset cancers and tumor biomarkers, including immune and microbial characteristics of cancer. Dr. Ugai is a founder of the International Cancer Spectrum Consortium, which is an interdisciplinary working group with faculty, postdocs, and students from various institutions all over the world. Dr. Ugai's group aims to build up a resource that integrates lifestyles and biomarkers including genetics and tissue molecular markers to (a) develop effective prevention and early-detection strategies, and (b) identify novel biomarkers to guide early-stage clinical decisions.
AACR Scholar-in-Training Award for AACR Annual Meeting 20232023
American Association for Cancer Research
Brigham and Women's Hospital Faculty Career Development Award2023
Brigham and Women's Hospital
MPE Rising Faculty Investigator Award2023
The 6th International MPE Meeting
Rose Traveling Fellowship Program in Chronic Disease Epidemiology and Biostatistics2022
Harvard Th. Chan School of Public Health
AACR Scholar-in-Training Award for AACR Special Conference: Colorectal Cancer2022
American Association for Cancer Research
Harvey V. Fineberg Fellowship in Cancer Prevention2022
Harvard Th. Chan School of Public Health
AACR Scholar-in-Training Award for AACR Annual Meeting 20222022
American Association for Cancer Research
Japanese Cancer Association Young Investigator Award2021
Japanese Cancer Association